Novo Nordisk's semaglutide, which could be the first oral alternative to injectable GLP-1 agonists in type 2 diabetes, has started phase III trials. If it reaches the market, the oral formulation ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Han malede børn, der blev vasket og skiftet, og blev kaldt »alt for intim« af sin samtid. »Den glemte skagensmaler« blev ...
On June 2, 2025, American Funds EuroPacific Growth will change its name to American Funds EUPAC. This move is meant to bring the fund's name in accordance with the US SEC's "names rule ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback